Filing Flows › GSK (GSK) › Gross margin
GSK (GSK) gross margin by quarter
GSK's gross margin was 73.1% in Q3 2026 (third quarter 2026), +0.1 pts from Q2 2026. Over the last 5 quarters it ranged from 72.9% (Q2 2025) to 75.4% (Q1 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 73.1% | +0.1 pts | -0.5 pts |
| Q2 2026 | 73.1% | -2.4 pts | +0.2 pts |
| Q1 2026 | 75.4% | +1.8 pts | — |
| Q3 2025 | 73.6% | +0.7 pts | — |
| Q2 2025 | 72.9% | — | — |
Q3 2026 at a glance
GSK, Q3 2026: revenue $8.9B (+4% year over year), operating margin 23.9%, net earnings $1.5B, operating cash flow $3.1B. The chart follows the revenue to costs, profit and cash.
Questions
What is GSK's gross margin?
GSK's gross margin was 73.1% in Q3 2026 (third quarter 2026), +0.1 pts from Q2 2026.
How has GSK's gross margin changed?
Over the last 5 quarters it ranged from 72.9% (Q2 2025) to 75.4% (Q1 2026).